A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs
Open Access
- 1 April 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (4) , 749-756
- https://doi.org/10.1038/mt.2008.3
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCsCarcinogenesis: Integrative Cancer Research, 2006
- Normal Stem Cells and Cancer Stem Cells: The Niche MattersCancer Research, 2006
- Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcomaThe Journal of Experimental Medicine, 2006
- Lymphatic vessels in cancer metastasis: bridging the gapsCarcinogenesis: Integrative Cancer Research, 2006
- 99mTc–Evans Blue Dye for Mapping Contiguous Lymph Node Sequences and Discriminating the Sentinel Lymph Node in an Ovine ModelAnnals of Surgical Oncology, 2006
- Therapeutic Modulation of Akt Activity and Antitumor Efficacy of Interleukin-12 Against Orthotopic Murine NeuroblastomaJNCI Journal of the National Cancer Institute, 2006
- Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapyCancer Science, 2005
- Study of Telomere Length Reveals Rapid Aging of Human Marrow Stromal Cells following In Vitro ExpansionThe International Journal of Cell Cloning, 2004
- In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunityGene Therapy, 2000
- Clinical Trials: IL-12 Deaths: Explanation and a PuzzleScience, 1995